SCHEMBL7922700

SCHEMBL7922700

COC(=O)CCc1ccc(OCCN(C)c2nc3ccccc3o2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PPARG P37231 20/20 1.00
PPARA Q07869 2/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9087947 0.94 PPARG (0.89) PPARGPPARA
SCHEMBL7825579 0.90 PPARG (0.81) PPARGPPARA
SCHEMBL9085087 0.90 PPARG (0.81) PPARGPPARA
SCHEMBL9086233 0.89 PPARG (0.80) PPARGPPARA
SCHEMBL9005926 0.86 PPARG (0.76) PPARGPPARA
SCHEMBL7826761 0.85 PPARG (0.74) PPARGPPARA
SCHEMBL9088332 0.84 PPARG (0.72) PPARGPPARA
SCHEMBL7909717 0.83 PPARG (0.80) PPARGPPARA
SCHEMBL5820207 0.83 PPARG (0.71) PPARGPPARA
SCHEMBL7824971 0.82 PPARG (0.78) PPARGPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6294580-B1 FOR THERAPY AND PROPHYLAXIS OF TYPE II OR NON-INSULIN DEPENDENT DIABETES MELLITUS, HYPERGLYCAEMIA, DYSLIPIDEMIA, TYPE II DIABETES, TYPE I DIABETES, HYPERTRIGLYCERIDEMIA, SYNDROME X, INSULIN RESISTANCE, HEART FAILURE GLAXO WELLCOME INC. 2001-09-25 US disclosed
EP-0888317-B1 SUBSTITUTED 4-HYDROXY-PHENYLALCANOIC ACID DERIVATIVES WITH AGONIST ACTIVITY TO PPAR-GAMMA GLAXO GROUP LTD (GB) 2001-09-12 EP disclosed
US-5589492-A Heterocyclic compounds and their use in the treatment of Type-II diabetes SMITHKLINE BEECHAM PLC (GB) 1996-12-31 US disclosed
WO-1995003288-A1 HETEROAROMATIC DERIVATIVES AND THEIR USE IN THERAPEUTICS SMITHKLINE BEECHAM PLC (GB) 1995-02-02 WO disclosed
EP-0635007-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE IN THE TREATMENT OF TYPE II-DIABETES SMITHKLINE BEECHAM PLC (GB) 1995-01-25 EP disclosed
WO-1993021166-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE IN THE TREATMENT OF TYPE II-DIABETES SMITHKLINE BEECHAM PLC (GB) 1993-10-28 WO disclosed